These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37805465)

  • 1. Assessing sex differences in viral load suppression and reported deaths using routinely collected program data from PEPFAR-supported countries in sub-Saharan Africa.
    Fernandez D; Ali H; Pals S; Alemnji G; Vasireddy V; Siberry GK; ; Oboho I; Godfrey C
    BMC Public Health; 2023 Oct; 23(1):1941. PubMed ID: 37805465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vital Signs: Progress Toward Eliminating HIV as a Global Public Health Threat Through Scale-Up of Antiretroviral Therapy and Health System Strengthening Supported by the U.S. President's Emergency Plan for AIDS Relief - Worldwide, 2004-2022.
    Chun HM; Dirlikov E; Cox MH; Sherlock MW; Obeng-Aduasare Y; Sato K; Voetsch AC; Ater AD; Romano ER; Tomlinson H; Modi S; Achrekar A; Nkengasong J;
    MMWR Morb Mortal Wkly Rep; 2023 Mar; 72(12):317-324. PubMed ID: 36952290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Threefold Increases in Population HIV Viral Load Suppression Among Men and Young Adults - Bukoba Municipal Council, Tanzania, 2014-2017.
    MacKellar D; Steiner C; Rwabiyago OE; Cham HJ; Pals S; Maruyama H; Msumi O; Kundi G; Byrd J; Weber R; Madevu-Matson C; Kazaura K; Rutachunzibwa T; Mmari E; Morales F; Justman J; Cain K; Rwebembera A
    MMWR Morb Mortal Wkly Rep; 2019 Aug; 68(30):658-663. PubMed ID: 31369522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of treatment outcomes for patients on first-line regimens in US President's Emergency Plan for AIDS Relief (PEPFAR) clinics in Uganda: predictors of virological and immunological response from RV288 analyses.
    Crawford KW; Wakabi S; Magala F; Kibuuka H; Liu M; Hamm TE
    HIV Med; 2015 Feb; 16(2):95-104. PubMed ID: 25124078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV Viral Load Monitoring Among Patients Receiving Antiretroviral Therapy - Eight Sub-Saharan Africa Countries, 2013-2018.
    Lecher SL; Fonjungo P; Ellenberger D; Toure CA; Alemnji G; Bowen N; Basiye F; Beukes A; Carmona S; de Klerk M; Diallo K; Dziuban E; Kiyaga C; Mbah H; Mengistu J; Mots'oane T; Mwangi C; Mwangi JW; Mwasekaga M; N'tale J; Naluguza M; Ssewanyana I; Stevens W; Zungu I; Bhairavabhotla R; Chun H; Gaffga N; Jadczak S; Lloyd S; Nguyen S; Pati R; Sleeman K; Zeh C; Zhang G; Alexander H
    MMWR Morb Mortal Wkly Rep; 2021 May; 70(21):775-778. PubMed ID: 34043612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating the impact of the US President's Emergency Plan for AIDS Relief on HIV treatment and prevention programmes in Africa.
    Heaton LM; Bouey PD; Fu J; Stover J; Fowler TB; Lyerla R; Mahy M
    Sex Transm Infect; 2015 Dec; 91(8):615-20. PubMed ID: 26056389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex Differences in HIV Testing - 20 PEPFAR-Supported Sub-Saharan African Countries, 2019.
    Drammeh B; Medley A; Dale H; De AK; Diekman S; Yee R; Aholou T; Lasry A; Auld A; Baack B; Duffus W; Shahul E; Wong V; Grillo M; Al-Samarrai T; Ally S; Nyangulu M; ; Nyirenda R; Olivier J; Chidarikire T; Khanyile N; Kayange AA; Rwabiyago OE; Kategile U; Bisimba J; Weber RA; Ncube G; Maguwu O; Pietersen I; Mali D; Dzinotyiweyi E; Nelson L; Bosco MJ; Dalsone K; Apolot M; Anangwe S; Soo LK; Mugambi M; Mbayiha A; Mugwaneza P; Malamba SS; Phiri A; ; Chisenga T; Boyd M; Temesgan C; Shimelis M; Weldegebreal T; Getachew M; Balachandra S; Eboi E; Shasha W; Doumatey N; Adjoua D; Meribe C; Gwamna J; Gado P; John-Dada I; Mukinda E; Lukusa LFK; Kalenga L; Bunga S; Achyut V; Mondi J; Loeto P; Mogomotsi G; Ledikwe J; Ramphalla P; Tlhomola M; Mirembe JK; Nkwoh T; Eno L; Bonono L; Honwana N; Chicuecue N; Simbine A; Malimane I; Dube L; Mirira M; Mndzebele P; Frawley A; Cardo YMR; Behel S
    MMWR Morb Mortal Wkly Rep; 2020 Dec; 69(48):1801-1806. PubMed ID: 33270608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excess mortality associated with mental illness in people living with HIV in Cape Town, South Africa: a cohort study using linked electronic health records.
    Haas AD; Ruffieux Y; van den Heuvel LL; Lund C; Boulle A; Euvrard J; Orrell C; Prozesky HW; Tiffin N; Lovero KL; Tlali M; Davies MA; Wainberg ML;
    Lancet Glob Health; 2020 Oct; 8(10):e1326-e1334. PubMed ID: 32971055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake of antiretroviral treatment and viral suppression among men who have sex with men and transgender women in sub-Saharan Africa in an observational cohort study: HPTN 075.
    Palumbo PJ; Zhang Y; Clarke W; Breaud A; Sivay M; Cummings V; Hamilton EL; Guo X; Ogendo A; Kayange N; Panchia R; Dominguez K; Chen YQ; Sandfort TGM; Eshleman SH
    Int J Infect Dis; 2021 Mar; 104():465-470. PubMed ID: 33440260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes.
    May M; Boulle A; Phiri S; Messou E; Myer L; Wood R; Keiser O; Sterne JA; Dabis F; Egger M;
    Lancet; 2010 Aug; 376(9739):449-57. PubMed ID: 20638120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with an interruption in treatment of people living with HIV in USAID-supported states in Nigeria: a retrospective study from 2000-2020.
    Tomescu S; Crompton T; Adebayo J; Kinge CW; Akpan F; Rennick M; Chasela C; Ondura E; Dauda DS; Pisa PT
    BMC Public Health; 2021 Nov; 21(1):2194. PubMed ID: 34847909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in Antiretroviral Therapy Eligibility and Coverage Among Children Aged <15 Years with HIV Infection - 20 PEPFAR-Supported Sub-Saharan African Countries, 2012-2016.
    Burrage A; Patel M; Mirkovic K; Dziuban E; Teferi W; Broyles L; Rivadeneira E
    MMWR Morb Mortal Wkly Rep; 2018 May; 67(19):552-555. PubMed ID: 29771871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing multimonth dispensing of antiretrovirals and assessing the effect on viral load suppression among children and adolescents receiving HIV services in Nigeria.
    Casalini C; Bateganya M; Akolo C; Sanwo O; Idemudia A; Nwaokoro P; Eyam F; Ogbechie MD; Obiora-Okafo C; Oduola A; Wilcher R; Mack N; Khamofu H; Pandey SR
    PLoS One; 2023; 18(6):e0286303. PubMed ID: 37315075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV development assistance and adult mortality in Africa.
    Bendavid E; Holmes CB; Bhattacharya J; Miller G
    JAMA; 2012 May; 307(19):2060-7. PubMed ID: 22665105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twelve-year mortality in adults initiating antiretroviral therapy in South Africa.
    Cornell M; Johnson LF; Wood R; Tanser F; Fox MP; Prozesky H; Schomaker M; Egger M; Davies MA; Boulle A;
    J Int AIDS Soc; 2017 Sep; 20(1):21902. PubMed ID: 28953328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The President's Emergency Plan for AIDS Relief and adult mortality: A replication study of HIV development assistance effects in Sub-Saharan African countries.
    Hein NA; Bagenda DS; Luo J
    PLoS One; 2020; 15(10):e0233948. PubMed ID: 33104731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Status of Adolescent Testing and Treatment in PEPFAR-Supported Programs, October 2017 to September 2020.
    Hrapcak S; Hast M; Okegbe T; Gross J; Williams J; Patel M; Wolf H; Siberry G; Lee L; Wiersma S; Agaba P; Carpenter D; Rivadeneira E;
    J Acquir Immune Defic Syndr; 2023 May; 93(1):15-24. PubMed ID: 36716723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards achieving the 90-90-90 HIV targets: results from the south African 2017 national HIV survey.
    Marinda E; Simbayi L; Zuma K; Zungu N; Moyo S; Kondlo L; Jooste S; Nadol P; Igumbor E; Dietrich C; Briggs-Hagen M
    BMC Public Health; 2020 Sep; 20(1):1375. PubMed ID: 32907565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Program-level and contextual-level determinants of low-median CD4+ cell count in cohorts of persons initiating ART in eight sub-Saharan African countries.
    Nash D; Wu Y; Elul B; Hoos D; El Sadr W;
    AIDS; 2011 Jul; 25(12):1523-33. PubMed ID: 21750418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial.
    Ciaffi L; Koulla-Shiro S; Sawadogo AB; Ndour CT; Eymard-Duvernay S; Mbouyap PR; Ayangma L; Zoungrana J; Gueye NFN; Diallo M; Izard S; Bado G; Kane CT; Aghokeng AF; Peeters M; Girard PM; Le Moing V; Reynes J; Delaporte E;
    Lancet HIV; 2017 Sep; 4(9):e384-e392. PubMed ID: 28566227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.